Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
<i>Background</i>. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Ou...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2023-08-01
|
| Rangatū: | Medicina |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/1648-9144/59/9/1560 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|